Connection

YUKA MORIKAWA to RNA, Messenger

This is a "connection" page, showing publications YUKA MORIKAWA has written about RNA, Messenger.
Connection Strength

0.050
  1. Hippo pathway deficiency reverses systolic heart failure after infarction. Nature. 2017 10 12; 550(7675):260-264.
    View in: PubMed
    Score: 0.022
  2. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats. J Pharmacol Exp Ther. 2016 09; 358(3):548-57.
    View in: PubMed
    Score: 0.020
  3. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett. 2003 Feb 11; 536(1-3):6-11.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.